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Objective. The purpose of the present study was to determine the effects of the surgical excision of lateral marginal veins
(LMVs) in patients with a venous malformation (VM) affecting the lower extremity.
Methods. Preoperative and postoperative air plethysmography (APG), CEAP classification C scores, and venous clinical
severity scores (VCSS) of the 25 VM patients who underwent LMV excision were compared.
Results. After LMVexcision, venous haemodynamic parameters revealed significantly increased ejection fraction (EF, 33.2
S.D.18.5% vs. 39.7 S.D.21.2%, P¼ .020), and reduced venous volume (VV, 235.0 S.D.141.8 ml vs. 198.0 S.D.114.1 ml,
P¼ .016) and residual venous fraction (RVF, 62.4 S.D. 26.6% vs. 56.9 S.D. 25.3%, P¼.046). Clinical assessments of
affected limbs revealed significantly improved mean CEAP C scores and VCSS (preoperative score, 4.4 S.D.1.7 vs. post-
operative score 2.4 S.D.1.7, P¼.026) after LMV excision versus preoperative data.
Conclusion. Haemodynamic and clinical improvements were observed in patients with lower extremity VM after LMV
excision.
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Congenital vascular malformations (CVMs) can be
classified as low-flow or high-flow. Low-flow malfor-
mations include venous, capillary, lymphatic, and
combined form malformations, whereas high-flow
malformations include arterial and arteriovenous
malformations.1 Venous malformations (VMs) com-
monly occur combined with capillary and/or lym-
phatic malformations (LMs). The presence of lateral
marginal vein (LMV) is not uncommon in patients
with a lower extremity VM. They are characterized
by a greater diameter than normal superficial veins
and a superficial location along the lateral aspect of
the lower extremity. They are also referred to as mar-
ginal veins, lateral embryonal veins, or as a lateral
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deep venous anomalies such as aplasia or hypoplasia.
In patients with deep venous aplasia of the lower ex-
tremity, LMV provides collateral venous channel for
the affected limb with other venous collaterals, such
as, an enlarged great saphenous vein or a persistent
sciatic vein.2
LMV provide a source of venous reflux due to the
absence of a venous valve, which can eventually cause
persistent venous hypertension of the lower extremity.
Though the precise mechanism is not known, chronic
venous hypertension during childhood has been sug-
gested as a cause of limb length discrepancy. Various
surgical procedures2,3 and embolisation procedures4,5
have been used to remove abnormal vessels and to
correct venous hypertension in patients with lower
extremity VM. However, we were unable to find a
report concerning the hemodynamic effects of LMV
excision in patients with VM. The aim of the present
study was to determine haemodynamic and clinical
outcomes after LMV excision in patients with a lower
extremity VM.
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Diagnosis and patient selection: BetweenMay 1996 to
October 2004, 580 patients with a VM (pure VM, 472
(81%) and combined type VM, 108 (19%)) registered
at the CVM clinic of the Samsung Medical Center,
Seoul. An analysis of the anatomic distribution of these
VM lesions revealed that lower limbs and buttocks
were the sites most frequently affected (Table 1).
To evaluate VMs, we performed whole body blood
pool scans (WBBPS) with radionuclide (99mTc labelled
RBC), MRI (Sigma horizon 1.5T, GE Medical,
Milwaukee, WI, USA), long bone spot scanography,
duplex ultrasonography (Ultramark9, ATL Inc, Bothell,
WA, USA) of the affected limb, and radionuclide
(Tc-99m antimony sulphide colloid) lymphoscinti-
graphy if indicated. The timings of these examina-
tions depended on patient age, clinical features, and
compliance.
Among the 274 patients with a lower extremity
VM, 98 (35.8%) patients had LMV by inspection or
by the above-described imaging studies. Of those
with an LMV, the frequency of an associated deep ve-
nous anomaly such as aplasia or hypoplasia (diameter
of hypoplastic segment of deep vein < 50% of adja-
cent vein diameter) was 13.3% (Fig. 1). We performed
LMV excisions in 25 limbs (right leg 9, left leg 16) of
25 patients (15 males, 10 females). Our indications
for LMV excision were prominent LMV accompanied
with clinical symptoms of chronic venous insuffi-
ciency (CVI), thrombus in LMV, or significant limb
length discrepancy (>2 cm) in paediatric patients
(Fig. 2). When LMV was associated with the deep ve-
nous agenesis or hypoplasia of the ipsilateral leg, we
Table 1. Anatomic distribution of venous malformations (VMs)
Distribution Type of Vascular Malformation Total (%)
Pure VM Combined VM with
LM and/or CM
Head and neck 120 32 152 (26.2)
Trunk: 37 3 40 (6.9)
Chest 20 2 22 (3.8)
Abdomen and
pelvis
11 1 12 (2.1)
Perineum,
genitalia
6 0 6 (1.0)
Extremity: 285 60 345 (59.5)
UE 60 11 71 (12.2)
LE and/or
buttock
225 49 274 (47.2)
Multi-focal 30 13 43 (7.4)
Total 472 108 580 (100)
VM, venous malformation; LM, lymphatic malformation; CM,
capillary malformation; UE, upper extremity; LE, lower extremity.regarded it as a contraindication for LMV excision.
We also excluded the patients from the candidate for
LMV excision when LMV was not prominent or the
clinical manifestation of CVI was absent or minimal.
Table 2 demonstrates the clinical features of the 25
patients who underwent LMV excision. One patient
with an LMV thrombus developed symptomatic pul-
monary embolism (PE) and an active venous ulcer
before LMV excision.
Preoperative preparation and operation: To pre-
dict the haemodynamic outcome of LMV excision,
we performed an LMV compression test preopera-
tively. The test was designed to observe the adaptabil-
ity of the deep venous system after LMV removal.
Using duplex ultrasonography, changes in maximal
diameter and deep vein flow velocity were measured
whilst manually compressing LMVs.
Before LMV excision, venous mapping was per-
formedbyultrasonography.Forpatientswithapotential
risk of a massive haemorrhage, such as, those with a
huge LMV, a sterile proximal thigh pneumatic cuff and
cell saver were prepared before making a skin incision.
For LMV excision, the LMV was exposed through
one or 2 longitudinal skin incisions under general
anesthesia. After exposing the LMV, ligation and
division of side branches, and secure suture closures
of its distal and proximal ends were performed before
removal.
In 18 patients, LMVs were excised in one stage (13
calf LMVs and 5 calf and thigh LMVs), whereas in 7
patients (28%) they were excised using staged opera-
tions (calf LMV excision first and thigh LMV excision
later). The decision whether to adopt a one-stage or
a two-stage operation was based on anatomical
Fig. 1. Selection of candidates for lateral marginal vein
(LMV) excisions among patients with a lower extremity
venous malformation (VM).Eur J Vasc Endovasc Surg Vol 33, January 2007
124 Y.-W. Kim et al.Fig. 2. Candidates for lateral marginal vein (LMV) excisions among patients with venous malformation; A, Prominent LMV
on the left leg: venous mapping before LMVexcision; B, Awhole body blood pool scan (WBBPS) revealed an LMV (arrow)
and a venous malformation (VM) in the left leg; C, Top: spiral CT scan revealing a pulmonary embolism (arrow) Bottom:
MRI shows a venous malformation in lower extremity muscle and an LMV thrombus (arrow) in a same patient; D, Scano-
gram of the lower extremity revealing a bone length discrepancy in a VM patient.features of the LMV and the patient’s ability to toler-
ate the operation. One of the reasons why we perform
LMVexcision as a staged operation was to avoid large
amounts of intraoperative bleeding, particularly in
paediatric patients. Another reason was to reduce
the sudden haemodynamic impact of LMV excision
on the deep venous system, as we expected patient
tolerance to increase to the new haemodynamic envi-
ronment after partial excision.
Following LMV excision, we provided bed rest
with leg elevation for a minimum of 24 hours, and
then initiated ambulation with an elastic compression
stocking as tolerated; generally longer bed rest was
required for haemostasis than for varicose stripping.
Low dose unfractionated heparin or prophylactic
low molecular weight heparin was given for a week.
Table 2. Preoperative demographic and clinical data of 25 patients
that underwent lateral marginal vein (LMV) excisions
Data N¼ 25
Age (y), Mean SD (Range) 17.2 12.6 (4e53)
Gender (Male : Female) 15 : 10
Involved limb (Right : Left) 9 : 16
Limb length discrepancy on
scanogram (n¼ 25)
Shorter Longer Subtotal
2 cm 1 1 2 (8%)
1e2 cm 0 6 6 (24%)









11/14 (78.6%)Eur J Vasc Endovasc Surg Vol 33, January 2007Assessment of surgical results: To evaluate the
haemodynamic effects of LMVexcision, we compared
preoperative and postoperative APG findings 1
month post-operatively. APG (ACI Medical, Sun
Valley, CA) was performed according to the protocol
described by Christopoulos et al.6,7 by registered vas-
cular technicians. Comparative APG data was avail-
able in 13 patients (7 calf LMV excisions, 6 calf and
thigh LMVexcisions), but unavailable in 12 paediatric
patients due to poor cooperation or the lack of appro-
priately sized cuffs.
We also assessed the clinical outcomes of LMV
excisions in all patients by comparing pre- and post-
operative C scores according to the CEAP classifi-
cation8 and venous clinical severity scores (VCSS).9
Postoperative clinical assessments were performed
at 25 S.D. 21 months (range 2e74 months) after LMV
excisions.
Statistical method: Data are presented as means
and S.D. and statistical significance was determined
using the paired t-test. P values of <0.05 were consid-
ered statistically significant.
Results
Preoperative ultrasonography of LMVs revealed ve-
nous reflux in all patients and thrombus in 3 (12%).
LMVs were distributed over the whole leg in 88% of
patients, and drained into the femoral vein in 84%
of patients (Table 3). A preoperative LMV compres-
sion test revealed increased diameter and flow veloc-
ity in deep veins during LMV compression (Table 4).
125Surgical Resection of Lateral Marginal VeinAfter LMV excisions, APG revealed a significantly
reduced postoperative venous volume (ml) and resid-
ual venous fraction (%) and an increased ejection frac-
tion (%) (Table 5). Clinical assessment using CEAP
classification C score and VCSS revealed an improved
clinical status after LMV excisions (Table 6).
No operative mortality or major morbidity oc-
curred during the early postoperative period, except
for lymphatic leakage from the wound in 3 patients.
All lymphatic leakages occurred in patients with a co-
existing lymphatic malformation. As a late complica-
tion, recurrent lymphangitis and cellulitis developed
in 2 patients (8%) on the operated limb.
Discussion
Klippel-Trenaunay syndrome (KTS) is a relatively
well-known type of CVM that is composed of venous,
lymphatic and capillary malformations, and which is
associated with soft tissue or bony limb hypertro-
phy.10 Two types of surgical treatment have been
attempted in patients with VM: reconstruction of
abnormal deep veins and ablation of abnormal veins.
Table 3. Location and morphologic features of lateral marginal
veins (LMVs) by duplex ultrasonography and MRI
Features of LMV N¼ 25
Location
Calf only 3 (12%)
Calf and thigh 14 (56%)
Calf, thigh, and buttock 8 (32%)
LMV drain into:
Popliteal vein 2 (8%)
Femoral vein 21 (84%)
Great saphenous vein 1 (4%)
Short saphenous vein 1 (4%)
Thrombus in LMV 3 (12%)












Diameter (mm) 5.4 2.9 6.0 3.3 13.8 10.1
Velocity (cm/s) 12.9 4.3 21.1 9.9 61.6 41.3
Popliteal vein:
Diameter (mm) 5.3 2.5 5.9 2.7 14.8 8.3
Velocity (cm/s) 11.1 6.9 16.5 8.8 8.4 39.3
a LMV compression test indicates the measurement of deep
venous diameter and flow velocity by duplex ultrasonography be-
fore and during manual compression of the lateral marginal vein
(LMV) in the supine position.For the reconstruction of the deep venous system, the
release of an extrinsic compressive band,2 competent
vein transposition,11 and deep venous reconstruction
using a contralateral saphenous vein graft12 have been
reported. Ablation procedures include the surgical
excisions of incompetent veins, such as, LMVs, saphe-
nous veins or varicosities13 and embolo-sclerotherapy
for abnormal venous clusters.5
We use embolo-sclerotherapy to treat diffuse infil-
trating VMs, though not for LMVs. There is a signifi-
cant risk of skin damage if a strong sclerosant is used
to treat a superficially located LMV. Though Jacob
et al.14 reported LMV in 72% of KTS, we found LMV
in 36% of lower extremity VM patients, which in-
cluded KTS and pure VM patients. Before excising
an LMV, an assessment of the deep venous system
is mandatory to avoid worsening venous hyperten-
sion caused by ablating an LMV in a patient with
deep venous hypoplasia or aplasia.
During LMV compressions above and below the
knee, we observed increased diameter and flow
Table 6. Clinical outcomes after lateral marginal vein (LMV)
excisions
Clinical outcomes No. of limb (%) P value
Preoperative Postoperative
C scorea .001c
C1 0 8 (32%)
C2 6 (24%) 1 (4%)
C3 15 (60%) 13 (52%),
C4 3 (12%) 2 (8%)
C5 0 1 (4%)
C6 1 (4%) 0
VCSSb 4.4 1.7 2.4 1.7 .026d
a C score according to CEAP classification. C1, telangiectases, re-
ticular veins, malleolar flare; C2, varicose veins; C3, edema without
skin changes; C4, skin changes ascribed to venous disease (e.g. pig-
mentation, venous eczema, lipodermatosclerosis); C5, skin changes
as defined above with healed ulceration; C6, skin changes defined
above with active ulceration.
b VCSS: venous clinical severity score.
c GEE, Generalized Estimating Equations.
d Paired t-test.
Table 5. Changes in air plethysmography (APG) parameters after
lateral marginal vein (LMV) excision (n[ 13 limbs)
APG parameter Mean SD P valuea
Preoperative Postoperative
Venous volume (ml) 235.0 141.8 198.0 114.1 .016
Venous filling
index (ml/sec)
5.3 6.4 3.2 2.6 .063
Ejection volume (ml) 68.9 58.8 67.9 41.5 .886
Ejection fraction (%) 33.2 18.5 39.7 21.2 .020
Residual venous
fraction (%)
62.4 26.6 56.9 25.3 .046
a Paired t-test.Eur J Vasc Endovasc Surg Vol 33, January 2007
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with non-stenotic deep venous system. In patients
with deep venous hypoplasia, we observed diameter
increase in the hypoplastic segment was minimal
but the venous flow velocity increased. This test pro-
vides physiological evidence of deep venous conges-
tion due to a sudden increase in blood flow into the
deep venous system after LMV excision. Though this
test requires further assessment to determine it value
in predicting venous gangrene, it can be used with
discretion as a part of an overall assessment to reduce
the risk of sudden venous congestion in patients with
deep venous aplasia or hypoplasia.
Eifert et al.15 reported that 47% of VM patients have
various types of deep venous anomalies, but deep ve-
nous aplasia or hypoplasia were reported to account
for only 8% of these anomalies. We found deep venous
aplasia or hypoplasia in 13% of patients with an LMV.
According to Servelle’s extensive review3 of surgical
KTS treatment, deep venous anomaly was identified
most often at the popliteal vein (51%), followed by the
femoral vein (16%), both femoral and popliteal veins
(29%), iliac vein (3.3%), and the inferior vena cava
(0.7%). In addition, they reported that venous aplasia
was more common at the femoral segment.
It is difficult to determine the effects of LMV
excision from previous reports, because of the range
of surgical procedures that were used.2,13 A recent
series6 reported clinical improvement but a high re-
currence rate for varicosities after treatment. How-
ever, their indications for surgical treatment differed
from ours. In particular, we observed LMV thrombus
in 3 patients (12%). In one of these 3 patients, symp-
tomatic PE coexisted at presentation although this
has only rarely been reported.16 During LMV exci-
sion, intraoperative haemorrhage is the main opera-
tive risk because bleeding from a primitive vessel is
difficult to control using standard vascular tech-
niques. In our series, 3 patients (12%) required a blood
transfusion of more than 5 units during LMV exci-
sion. We recommend that pneumatic tourniquet
compression of the leg and the use of a cell saver
machine when massive bleeding occurs during LMV
excision.
Leg length discrepancy is another important issue in
patients with a CVM. Some previous reports have sug-
gested that early, active vascular interventions used to
correct venous hypertension can prevent lower limb
length discrepancy in paediatric VM patients.17,18 The
effect of LMVexcision on bone growth has not been de-
termined but we recommend LMVexcision before the
completion of long bone growth or the development
of the advanced signs of CVI. The mean age of our
patients was 17.2 S.D. 12.6 years in the present series.Eur J Vasc Endovasc Surg Vol 33, January 2007Lymphatic anomalies may not be clinically appar-
ent until a later in life in cases of combined type
veno-lymphatic malformations. Radionuclide lym-
phoscintigraphy showed main lymphatic channel
obstruction while others showed diminished lym-
phatic clearance without major channel obstruction.
We experienced 2 patients who developed worsening
late limb swelling due to recurrent lymphangitis and
cellulitis following LMV excision. In these 2 patients,
a preoperative lymphoscintigram showed diminished
lymphatic clearance without major lymphatic obstruc-
tion in the affected limb, and follow-up lympho-
scintigram showed further diminution of lymphatic
clearance after LMV excision.
For patients with lymphangitis, CEAP classification
C scores did not reflect worsening of limb swelling,
though a comparison of pre- and postoperative
C-scores showed a statistically significant improve-
ment. In the present study, we found that CEAP clas-
sification C scores are inappropriate for outcome
assessment in VM patients.
Other reports have described the role of APG in the
haemodynamic assessment of CVI,19,20 and in the post-
operative evaluation of superficial vein ablation in CVI
patients.21,22 Although we accept that APG cannot
provide complex haemodynamic information in VM
patients, we observed that venous haemodynamics
were significantly improved after LMVexcision.
Two major complications of LMVexcision are intra-
operative haemorrhage and the late occurrence of lym-
phangitis and cellulitis. To avoid the operative risk of
haemorrhage, we believe that endovascular LMVabla-
tion may become a future alternative option. However,
preoperative lymphoscintigraphic findings of a patent
main lymphatic channel cannot guarantee freedom
from later lymphatic complications after LEVexcision.
We recommend LMV excision in patients with
a prominent LMV with clinical manifestations of
CVI or of thrombus in an LMV. Even though we do
not provide evidence of the beneficial effect of LMV
excision in paediatric patients with a leg length dis-
crepancy, the long-term outcome of its effect on
bone growth should be followed in this patient group.
Before LMV excision is considered, anatomical and
functional assessments of the deep venous system
with imaging studies and LMV compression ultra-
sonography help in the selection of suitable patients.
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